Gene Activating and Proapoptotic Potential are Independent Properties of Different CD4 Epitopes

Molecular Immunology

Volumn 34, Issue 4, 1997, Pages 287-296

  Milia, Elisabetta ^a   Di Somma, M Maddalena ^a,b   Majolini, M Bernardetta ^a   Ulivieri, Cristina ^a   Somma, Francesca ^c   Piccolella, Enza ^c   Telford, John L ^b   Baldari, Cosima T ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b CHIRON VACCINES   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CD4; HIV 1 gp120; NF AT; p561ck; Shc

Indexed keywords

CD4 ANTIGEN; EPITOPE; GLYCOPROTEIN GP 120; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CELL DEATH; ENZYME ACTIVITY; GENE ACTIVATION; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; APOPTOSIS; DNA-BINDING PROTEINS; EPITOPES; GENE EXPRESSION REGULATION; HIV ENVELOPE PROTEIN GP120; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030748210     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(97)00050-3     Document Type: Article

References (50)

1. Baldari C. T., Di Somma M. M., Milia E., Bergman M. and Telford J. L. (1995) Interactions between the tyrosine kinases p561ck, p59fyn and p50csk in CD4 signaling in T cells. European Journal of Immunology 25, 919-925.
2. Baldari C. T., Milia E., Di Somma M. M., Baldoni F., Valitutti S. and Telford J. L. (1995) Distint signaling properties identify functionally different CD4 epitopes. European Journal of Immunology 25, 1843-1850.
3. Baldari C. T., Pelicci G., Di Somma M. M., Milia E., Giuli S., Pelicci P. G. and Telford J. L. (1995) Inhibition of CD4/p561ck signaling by a dominant negative mutant of the She adaptor protein. Oncogene 10, 1141-1147.
4. Banda N. K., Bernier J., Kurahara D. K., Kurrle R., Haigwood N., Sekaly R.-P. and Finkel T. H. (1992) Cross-linking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. Journal of Experimental Medicine 176, 1099-1106.
5. Benkirane M., Jeang K.-T. and Devaux C. (1994) The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T-cells. EMBO Journal 23, 5559-5569.
6. Benkirane M., Schmid-Antomarchi H., Littman D. R., Hirn M., Rossi B. and Devaux C. (1995) The cytoplasmic tail of CD4 is required for inhibition of human immunodeficiency virus type 1 replication by antibodies that bind to the immunoglobulin CDR3-like region of domain 1 of CD4. Journal of Virology 69, 6904-6910.
7. Berger E. A., Fuerst T. R. and Moss B. (1988) A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus. Proceedings of the National Academy of Science U.S.A. 85, 2357-2361.
8. Borst J., Dongen J. J. van, Vries E. de, Comans-Bitter W. M., Tol M. J. D. van, Vossen J. M. and Kurrle R. (1990) BMA-031, a monoclonal antibody suited to identify the T-cell receptor alpha beta CD3 complex on viable human T lymphocytes in normal and disease states. Human Immunology 29, 175-180.
9. Bowman M. R., MacFerrin K. D., Schreiber S. L. and Burakoff S. J. (1990) Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules. Proceedings of the National Academy of Science U.S.A. 87, 9052-9056.
10. + peripheral blood T lymphocytes induced by anti-CD4 monoclonal antibody. European Journal of Immunology 18, 333-339.
11. Celada F., Cambiaggi C., Maccari J., Burastero S., Gregory T., Patzer E., Porter J., McDanal C. and Matthews T. (1990) Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding. Journal of Experimental Medicine 172, 1143-1150.
12. + T cells. Journal of Biology and Chemistry 270, 19364-19369.
13. Clayton L. K., Sieh M., Pious D. A. and Reinherz E. L. (1989) Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature 339, 548-551.
14. Cohen J. J. (1993) Apoptosis. Immunology Today 14, 126-130.
15. Corbeil J., Tremblay M. and Richman D. D. (1996) HIV-induced apoptosis requires the CD4 receptor cytoplasmic tail and is accelerated by interaction of CD4 with p561ck. Journal of Experimental Medicine 183, 39-48.
16. Dhein J., Walczak H., Baumler C., Debatim K.-M. and Krammer P. H. (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438-441.
17. Di Somma M. M., Nuti S., Telford J. L. and Baldari C. T. (1995) p561ck plays a key role in transducing apoptotic signals in T cells. FEBS Letters 363, 101-104.
18. + T cell function by the HIV envelope glycoprotein, gp120. Journal of Immunology 141, 3715-3717.
19. lck interacts via its src homology 2 domain with the ZAP-70 kinase. Journal of Experimental Medicine 179, 1163-1172.
20. Emmel E. A., Verweij C. L., Durand D. B., Higgins K. M., Lacy E. and Crabtree G. R. (1989) Cyclosporin A specifically inhibits function of nuclear proteins involved in T-cell activation. Science 246, 1617-1620.
21. Gaynor R. (1992) Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6, 347-363.
22. lck with CD4 in antigen-specific signal transduction in T cells. Cell 64, 511-520.
23. Green D. R. and Scott D. W. (1994) Activation-induced apoptosis in lymphocytes. Current Opinions in Immunology 6, 476-487.
24. Haigwood, N. L., Barker, C. B., Higgins, K. S., Skiles, P. V., Moore G. K., Mann K. A., Lee D. R., Eichberg J. W. and Steimer K. S. (1990) Evidence for neutralizing antibodies directed against conformational epitopes of HIV-1 gp120. In Vaccines Vol. 90, pp. 131-139. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
25. Janeway C. A. Jr and Bottomly K. (1994) Signals and signs for lymphocyte responses. Cell 76, 275-285.
26. Lamarre D., Ashkenazi A., Fleury S., Smith D. H., Sekaly R.-P. and Capon D. J. (1989) The MHC-binding and gp120-binding functions of CD4 are separable. Science 245, 743-745.
27. Ledbetter J. A., Deans J. P., Aruffo A., Grosmaire L. S., Kanner S. B., Bolen J. B. and Schieven J. L. (1993) CD4, CD8 and the role of CD45 in T-cell activation. Current Opinions in Immunology 5, 334-340.
28. Lemasson I., Briant L., Hague B., Coudronniere N., Heron L., David C., Rebouissou C., Kindt T. and Devaux C. (1996) An antibody that binds domain 1 of CD4 inhibits replication of HIV-1, but not HTLV-I, in a CD4-positive/p561ck-negative HTLV-I-transformed cell line. Journal of Immunology 156, 859-865.
29. Lombardi G., Sidhu S., Dodi T., Batchelor R. and Lechler R. (1994) Failure of correlation between B7 expression and activation of interleukin-2-secreting T cells. European Journal of Immunology 24, 523-530.
30. Lynch D. H., Ramsdell F. and Alderson M. R. (1995) Fas and FasL in the homeostatic regulation of immune responses. Immunology Today 16, 569-574.
31. Milia E., Di Somma M. M., Baldoni F., Chiari R., Lanfrancone L., Pelicci P. G., Telford J. L. and Baldari C. T. (1996) The aminoterminal phosphotyrosine binding domain of She associates with ZAP-70 and mediates TCR dependent gene activation. Oncogene 13, 767-775.
32. Newell M. K., Haughn L. J., Maroun C. R. and Julius M. H. (1990) Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 347, 286-289.
33. Oyazu N., McCloskey T. W., Than S., Hu R., Kalyanaraman V. S. and Pahwa S. (1994) Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis-alpha secretion. Blood 84, 2622-2631.
34. Pelicci G., Lanfrancone L., Grignani F., McGlade J., Cavallo F., Forni G., Nicoletti I., Pawson T. and Pelicci P. G. (1992) A novel trasforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70, 93-104.
35. Peterson A. and Seed B. (1988) Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 54, 65-72.
36. Piatier-Tonneau D., Gastinel L.-N., Moussy G., Benichou B., Amblard F., Vaigot P. and Auffray C. (1991) Mutations in the D strand of the human CD4 V1 domain affect CD4 interactions with the human immunodeficiency virus envelope glycoprotein gp120 and HLA class II antigens similarly. Proceedings of the National Academy of Sciences U.S.A. 88, 6858-6862.
37. Prasad K. V., Kapeller R., Jansenn O., Repke H., Duke-Cohan J. S., Cantley L. C. and Rudd C. E. (1993) Phosphatidylinositol (PI) 3-kinase and PI 4-kinase binding to the CD4-p56lck complex: the p56lck SH3 domain binds to PI 3-kinase but not PI 4-kinase. Molecular and Cellular Biology 13, 7708-7717.
38. Rudd C. E., Trevillyan J. M., Dasgupta J. D., Wong L. L. and Schossman S. F. (1988) The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. Proceedings of the National Academy of Sciences U.S..A. 85, 5190-5194.
39. Schmid-Antomarchi H., Benkirane M., Breittmayer V., Husson H., Ticchioni M., Devaux C. and Rossi B. (1996) HIV induces activation of phosphatidylinositol 4-kinase and mitogen-activated protein kinase by interacting with T cell CD4 surface molecules. European Journal of Immunology 26, 717-720.
40. Settanteau Q. J., Arthos J., Deen K., Hanna N., Healy D., Beverly P. C. L., Sweet R. and Truneh A. (1989) Structural analysis of the human immunodeficiency virus-binding domain of CD4. Journal of Experimental Medicine 170, 1319-1334
41. Steimer, K. S., Nest, G. A. van, Haigwood, N. L., Tillson, E. M., George-Nascimento E. M., Barr P. J. and Dina D. (1988) Recombinant env and gag polypeptides in characterizing HIV-1 neutralizing antibodies. In Vaccines Vol. 88, pp.347-357. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
42. Straus D. B. and Weiss A. (1992) Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70, 585-593.
43. Thompson P. A., Gutkind J. S., Robbins K. C., Ledbetter J. A. and Bolen J. B. (1992) Identification of distict populations of PI-3 kinase activity following T-cell activation. Oncogene 7, 719-725.
44. + T-cell populations. European Journal of Immunology 25, 2907-2916.
45. Ullman K. S., Northrop J. P., Verweij C. L., Crabtree G. R. (1990) Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annual Review of Immunology 8, 421-452.
46. lck. Nature 338, 257-259.
47. Wang J., Yan Y., Garrett T. P. J., Liu J., Rodgers D. W., Garlick R. L., Tarr G. E., Husain Y., Reinherz E. L. and Harrison S. C. (1990) Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348, 411-418.
48. Weiss A. and Littman D. R. (1994) Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274.
49. Westerndorp M. O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K.-M. and Krammer P. H. (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375, 497-500.
50. Wilks D., Walker L., O'Brien J., Habeshaw J. and Dalgleish A. (1990) Differences in affinity of anti-CD4 monoclonal antibodies predict their effects on syncitium induction by immunodeficiency virus. Immunology 71, 10-15.